A daily fibre supplement eased knee arthritis pain and boosted grip strength

Knee osteoarthritis is one of the most common sources of chronic pain in older adults, and the best established non-drug treatment is exercise supported by physiotherapy, which improves both pain and function. Meanwhile, evidence has been building that the gut microbiome plays a role in how chronic pain is processed, which raises an intriguing possibility: could changing the gut change the pain? Inulin is a prebiotic fibre known to modulate the gut microbiome, and this trial set out to test whether supplementing it could ease knee osteoarthritis pain, on its own or alongside a physiotherapy-supported exercise programme.

The researchers ran a factorial randomised trial in 117 community-dwelling adults with knee osteoarthritis, 58.1% of them female with a mean age of 67.5 years. For 6 weeks, participants received one of four options: 20 g a day of inulin, a digital physiotherapy-supported exercise programme called Joint Academy, both together, or 10 g a day of maltodextrin as a placebo. The primary outcome was pain on a numerical rating scale. Secondary measures included a 30-second sit-to-stand test, the timed up and go test, grip strength and quantitative sensory testing of pain sensitivity, and blood levels of short-chain fatty acids and the hormone GLP-1 were tracked. The study was not powered to detect a synergistic interaction between the two treatments.

Both treatments beat placebo on pain: inulin by 1.11 points and the exercise programme by 1.55 points on the rating scale, with no sign the combination added anything extra. The exercise programme improved the timed up and go and sit-to-stand tests, while inulin improved grip strength along with pressure pain thresholds and temporal summation, two laboratory measures of pain sensitivity. Only inulin raised the short-chain fatty acid butyrate and GLP-1, and higher GLP-1 tracked with better grip strength, which the authors suggest hints at a gut-muscle link. Dropout told its own story: 3.6% of the inulin group left the trial against 21% of the exercise group.

This moves the gut-pain hypothesis from association studies into a randomised test in a common, self-managed condition, and its results sit comfortably alongside the established benefit of exercise for knee osteoarthritis. The finding that only inulin shifted pain sensitivity and grip strength is new and will need replication before it can be trusted. Open questions remain: whether the benefit outlasts six weeks of supplementation, whether it holds in larger and more diverse groups, and whether the butyrate and GLP-1 changes actually drive the improvements or merely accompany them. The trial also could not properly test whether fibre and exercise combine, since it was not powered for that comparison.

For anyone managing knee osteoarthritis, this is a reason to think the gut may be part of the pain picture, not just the joint itself. A cheap prebiotic fibre produced a modest but real pain reduction over six weeks in this trial, and nearly everyone assigned to it stayed the course, which matters for anything a person has to sustain long term. It does not displace exercise, which produced the larger pain improvement and better scores on the function tests. This is one trial, so treat it as information worth watching rather than a settled option.